{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-001358","form_type":"8-K","ticker":"BBIO","cik":"0001743881","company_name":"BridgeBio Pharma, Inc.","filed_at":"2024-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.367129+00:00","generated_at":"2026-06-07T02:25:16.978214+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"BridgeBio Pharma presents business update at 42nd Annual J.P. Morgan Healthcare Conference","bullets":["BridgeBio Pharma presented a business update at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024.","The presentation slides were filed as Exhibit 99.1 to the Form 8-K and published on the company's website.","The update was signed by CFO Brian C. Stephenson."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-001358","json":"https://secwatch.observer/filing/0001140361-24-001358.json","markdown":"https://secwatch.observer/filing/0001140361-24-001358.md","text":"https://secwatch.observer/filing/0001140361-24-001358.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1743881/000114036124001358/0001140361-24-001358-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1743881/000114036124001358/ef20018306_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T02:25:16.978214+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}